Biological pesticide for preventing and treating tobacco wild fire disease

CN117796405BActive Publication Date: 2026-09-04HECHI TOBACCO CO OF GUANGXI ZHUANG AUTONOMOUS REGION +1
View PDF 2 Cites 0 Cited by

Patent Information

Application Number
CN202311795900.5
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2023-12-25
Publication Date
2026-09-04
Estimated Expiration
2043-12-25

AI Technical Summary

Technical Problem

现有技术已公开,申嗪霉素与壬菌铜、噻霉酮、乙蒜素、噻菌铜或中生菌素复配可以防治细菌性病害,但目前还未见到申嗪霉素与甲磺酰菌唑或大黄酚复配的相关报道

Benefits of technology

[0014](1)本发明生物农药活性成分由申嗪霉素与甲磺酰菌唑或大黄酚复配而成,通过滤纸片扩散法验证发现,本发明生物农药的复配配方对引起烟草野火病的烟草假单胞杆菌具有增效作用,与单剂相比,可以提高对烟草野火病的防治效果。

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure BDA0004627692900000031
    Figure BDA0004627692900000031
  • Figure BDA0004627692900000041
    Figure BDA0004627692900000041
  • Figure BDA0004627692900000051
    Figure BDA0004627692900000051
Patent Text Reader

Abstract

The present application belongs to the technical field of biological pesticides, and particularly relates to a biological pesticide for preventing and treating tobacco wild fire disease. The active ingredient of the biological pesticide is prepared by compounding shenzimycin, thiochlorfenazole and rheochrysidin at a mass ratio of 1-80:80-1. The active ingredient of the biological pesticide is prepared by compounding shenzimycin, thiochlorfenazole and rheochrysidin. It is found by the filter paper diffusion method that the compounding formula of the biological pesticide has a synergistic effect on tobacco Pseudomonas syringae which causes tobacco wild fire disease, and can improve the prevention and treatment effect on tobacco wild fire disease compared with a single agent.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] This invention belongs to the field of biological pesticide technology, specifically relating to a biological pesticide for preventing and controlling tobacco wildfire disease. Background Technology

[0002] Tobacco wildfire disease is a bacterial disease of tobacco caused by *Pseudomonas syringae* pv. *tabaci*. It can occur in both seedbeds and fields, primarily affecting leaves, but can also damage young stems, capsules, and sepals. Initially, infected leaves develop small, brown, water-soaked spots surrounded by a distinct yellow halo. In rainy and humid weather, these spots enlarge and merge, forming irregular, large brown patches. In dry weather, the spots crack and fall off, causing leaf fragmentation. Infected young stems, capsules, and sepals develop irregular small spots, initially water-soaked, later turning brown with indistinct halos. In rainy and humid weather, affected seedlings rot and collapse, or only the terminal bud remains upright, pale and weak, partially scorched and broken, eventually dying, resembling a wildfire.

[0003] Currently, there are relatively few pesticides on the market for controlling bacterial diseases, and the variety is limited, mainly focusing on copper-based agents and agricultural antibiotics. Furthermore, long-term application of single agents can easily lead to drug resistance in pathogens, environmental pollution, and pesticide residues.

[0004] Shenqinmycin is an antibiotic secreted by *Pseudomonas fluorescens* M18 through biological culture. It is a fungicide with dual effects, possessing broad-spectrum inhibition of plant pathogens and promoting plant growth. It is also a biological pesticide with independent intellectual property rights in my country. Existing technology has been disclosed; shenqinmycin, when combined with copper oxychloride, thiamethoxam, ethoxysulfuron, thiamethoxam, or streptomycin, can control bacterial diseases. However, there are currently no reports of shenqinmycin being combined with mesylate or rhein. Summary of the Invention

[0005] The purpose of this invention is to provide a biological pesticide for controlling tobacco wildfire disease, which can improve the control effect of tobacco wildfire disease, enrich the variety of bactericidal agents, delay the development of pathogenic bacteria resistance to agents, and is of great significance for providing new and efficient agents for controlling bacterial diseases in tobacco production.

[0006] To achieve the above objectives, the present invention provides the following technical solution:

[0007] A biological pesticide for preventing tobacco wildfire disease, wherein the active ingredient of the biological pesticide is a compound of shenqinmycin and mesylate or rhein in a mass ratio of 1-80:80-1.

[0008] Preferably, the mass ratio of shenqinmycin to mesylate is 1-20:8-1.

[0009] Preferably, the mass ratio of shenqinmycin to mesylate is 1:2.

[0010] Preferably, the mass ratio of shenqinmycin to rhein is 1-10:10-1.

[0011] Preferably, the mass ratio of shenqinmycin to rhein is 5:1.

[0012] The present invention also provides the use of the aforementioned biological pesticide in the prevention and control of tobacco wildfire disease.

[0013] Compared with the prior art, the present invention has the following beneficial effects:

[0014] (1) The active ingredient of the biological pesticide of the present invention is a compound of shenqinmycin and mesotrione or rhein. The filter paper diffusion method was used to verify that the compound formulation of the biological pesticide of the present invention has a synergistic effect on Pseudomonas tobacco, which causes tobacco wildfire, and can improve the control effect on tobacco wildfire compared with single agent.

[0015] (2) The biological pesticide of the present invention is a novel biological pesticide with the characteristics of low toxicity, low residue and low pollution.

[0016] (3) The biological pesticide of the present invention can enrich the variety of bactericidal agents, delay the development of pathogenic bacteria resistance to agents, and provide new and efficient agents for the prevention and control of bacterial diseases in tobacco production, which is of great significance. Detailed Implementation

[0017] The technical solution of this invention patent will be clearly and completely described below. Obviously, the described embodiments are only some, not all, of the embodiments of this invention. Based on the embodiments of this invention, all other embodiments obtained by those skilled in the art without inventive effort are within the scope of protection of this invention.

[0018] Example Indoor activity test

[0019] 1. Test pathogens

[0020] Pseudomonas syringae pv. tabaci was isolated from infected tobacco samples and preserved in the laboratory.

[0021] 2. Culture medium

[0022] NA medium: 5g peptone, 3g beef extract, 2.5g glucose, 15g agar powder, add distilled water to a final volume of 1L, natural pH.

[0023] NB medium: 5g peptone, 3g beef extract, 2.5g glucose, add distilled water to a final volume of 1L, natural pH.

[0024] 3. Test reagents

[0025] 95% Shenqinmycin technical grade (Shanghai Nongle Biological Products Co., Ltd.), 96.5% Mesylatezazole technical grade (Guangxi Tianyuan Biochemical Co., Ltd.), 98% Rhein technical grade (Zhengzhou Huiju Chemical Co., Ltd.).

[0026] After the test reagent is completely dissolved, it is diluted with 0.1% Tween-80 to prepare a single-agent stock solution with a concentration of 10000 mg / L. Then, multiple sets of ratios are set up, and each single-agent stock solution and each mixed reagent are set up with 0.1% Tween-80 in a proportional manner to form 5 series of mass concentration gradients for later use.

[0027] 4. Test methods

[0028] Referencing the filter paper diffusion method of Wei Haijuan et al. (2011), the test pathogens were cultured in a NA culture medium at 30℃ for 24 h. Two loops of colonies were picked and placed in 100 mL of NB culture medium, and cultured with shaking at 30℃ and 180 r / min for 24 h. The bacterial suspension concentration was then adjusted to 1.0 × 10⁻⁶ using a hemocytometer. 8 CFU / mL. When the temperature of the sterile NA medium drops to approximately 50°C, pour 10 mL into each 9 cm diameter petri dish, shake well, and allow to cool to form a plate. Spread 50 μL of bacterial suspension evenly onto the cooled NA plate. Punch 5 mm diameter filter paper discs, sterilize them, and immerse them in the drug solution for 1 hour. Remove the discs, drain excess solution, and place them in the center of each bacterial plate, one filter paper disc per plate. Use filter paper discs soaked in 0.1% Tween-80 aqueous solution as a blank control. Repeat each treatment three times. Incubate at 30°C for 48 hours. Measure the diameter of the inhibition zone using the cross-sectional method and calculate the inhibition rate.

[0029]

[0030] 5. Data Analysis

[0031] The drug concentration was converted to a logarithmic value, and the corresponding inhibition rate was converted to a probability value. A regression equation for virulence and EC was calculated with the logarithmic concentration as the independent variable and the inhibition rate probability value as the dependent variable. 50 The co-toxicity coefficient (CTC value) of the mixture was calculated according to Sun Yunpei's method. The experimental results are shown in Table 1-2.

[0032] Table 1. Indoor bioactivity assay of shenqinmycin and mesylate combined with Pseudomonas tobacco.

[0033] Shenqinmycin 34.0928 100.0000 -- -- Methionazole 14.3427 237.7014 -- -- Shenqinmycin 1: Mesylate 10 15.3004 222.8229 225.1831 98.9519 Shenqinmycin 1: Mesylatezazole 8 11.9553 285.1689 222.4013 128.2227 Shenqinmycin 1: Mesylatezazole 5 7.5717 450.2661 214.7512 209.6688 Shenqinmycin 1: Mesylatezazole 2 2.0031 1702.0019 191.8009 887.3793 Shenqinmycin 1: Mesylatezazole 1 10.1731 335.1270 168.8507 198.4753 Shenqinmycin 2: Mesylatezazole 1 16.7509 203.5282 145.9005 139.4980 Shenqinmycin 5: Mesylatezazole 1 22.6162 150.7450 122.9502 122.6066 Shenqinmycin 10: Mesylate 1 19.7025 173.0379 112.5183 153.7865 Shenqinmycin 20: Mesylate 1 24.1407 141.2254 106.5572 132.5348 Shenqinmycin 25: Mesylatezazole 1 39.1165 87.1571 105.2962 82.7732

[0034] Table 1 shows that the co-toxicity coefficient of shenqinmycin and mesylate-based sulfadiazine against *Pseudomonas tobaccois* is greater than 120 within a mass ratio of 1-20:8-1, indicating a synergistic effect; the synergistic effect is most significant when the mass ratio is 1:2. This demonstrates that the formulation of shenqinmycin and mesylate-based sulfadiazine in this invention can improve the control effect against tobacco wildfire disease.

[0035] Table 2. Indoor bioactivity assay of shenqinmycin and rhein combined with Pseudomonas aeruginosa.

[0036]

[0037]

[0038] Table 2 shows that the co-toxicity coefficient of shenqinmycin and rhein against *Pseudomonas tobaccoii* is greater than 120 within a mass ratio of 1-10:10-1, indicating a synergistic effect; the synergistic effect is most significant when the mass ratio is 5:1. This demonstrates that the formulation of shenqinmycin and rhein of this invention can improve the control effect against tobacco wildfire disease.

[0039] In summary, the active ingredient of the biopesticide of this invention is a compound of shenqinmycin and mesylate or rhein. Verification by the filter paper diffusion method revealed that the compound formulation of the biopesticide of this invention has a synergistic effect on Pseudomonas tobaccoii, which causes tobacco wildfire. Compared with single agents, it can improve the control effect on tobacco wildfire, enrich the variety of bactericidal agents, delay the development of drug resistance in pathogenic bacteria, and is of great significance for providing new and highly effective agents for the control of bacterial diseases in tobacco production.

[0040] The foregoing description of specific exemplary embodiments of the invention is for illustrative and explanatory purposes. These descriptions are not intended to limit the invention to the precise forms disclosed, and it will be apparent that many changes and variations can be made in accordance with the foregoing teachings. The exemplary embodiments were chosen and described in order to explain the specific principles of the invention and its practical application, thereby enabling those skilled in the art to implement and utilize various different exemplary embodiments of the invention, as well as various different choices and variations. The scope of the invention is intended to be defined by the claims and their equivalents.

Claims

1. A biological pesticide, characterized in that, The active ingredient of the biological pesticide is a compound of shenqinmycin and mesylate in a mass ratio of 1-20:8-1.

2. The biological pesticide according to claim 1, characterized in that, The mass ratio of shenqinmycin to mesylate is 1:

2.

3. The use of the biological pesticide according to any one of claims 1-2 in the prevention and control of tobacco wildfire disease.

Citation Information

Patent Citations

  • High-efficiency, broad-spectrum, low-toxicity and environmentally-friendly agricultural new compounds and composition thereof

    CN110881476A

  • Broad-spectrum bactericidal pollution-free growth-promoting thiazole manganese-zinc compound and composition thereof

    CN111138379A